A forward-genetic approach for analysis of the immune system

Nature Reviews Immunology

Volumn 3, Issue 6, 2003, Pages 463-471

  Appleby, Mark W ^a   Ramsdell, Fred ^a  

^a Celltech R and D Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNE SYSTEM; IMMUNOGENETICS; KNOCKOUT MOUSE; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; ANIMAL; COMPARATIVE STUDY; GENE; GENOME; MOUSE MUTANT; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

ETHYLNITROSOUREA;

ANIMALS; ETHYLNITROSOUREA; GENES; GENOME, HUMAN; HUMANS; IMMUNE SYSTEM; MICE; MICE, MUTANT STRAINS; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE;

EID: 0038820034     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1109     Document Type: Review

References (28)

1. Russ, A. et al. Random mutagenesis in the mouse as a tool in drug discovery. Drug Discov. Today 7, 1175-1183 (2002).
2. Samelson, L. E. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20, 371-394 (2002).
3. Koretzky, G. A. & Myung, P. S. Positive and negative regulation of T-cell activation by adaptor proteins. Nature Rev. Immunol. 1, 95-107 (2001).
4. Nadeau, J. H. et al. Sequence interpretation. Functional annotation of mouse genome sequences. Science 291, 1251-1255 (2001).
5. Perkins, A. S. Functional genomics in the mouse. Funct. Integr. Genomics 2, 81-91 (2002).
6. Sauer, B. Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392 (1998).
7. Zinkernagel, R. M. & Doherty, P. C. The discovery of MHC restriction. Immunol. Today 18, 14-17 (1997).
8. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933-944 (2002).
9. Brown, S. D. & Peters, J. Combining mutagenesis and genomics in the mouse-closing the phenotype gap. Trends Genet. 12, 433-435 (1996). This paper introduces the concept of the 'phenotype gap' - the disparity between the available mouse mutant resource and the range of additional phenotypes that are required to fully exploit the mouse as a model of human disease.
10. Koonin, E. V., Wolf, Y. I. & Karev, G. P. The structure of the protein universe and genome evolution. Nature 420, 218-223 (2002).
11. Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
12. Samelson, L. E. Lymphocyte activation. Curr. Opin. Immunol. 2, 210-214 (1989).
13. Klinghoffer, R. A., Hamilton, T. G., Hoch, R. & Soriano, P. An allelic series at the PDGFαR locus indicates unequal contributions of distinct signaling pathways during development. Dev. Cell 2, 103-113 (2002).
14. Vivian, J. L., Chen, Y., Yee, D., Schneider, E. & Magnuson, T. Anh allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N-nitrosourea-mutagenized mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 15542-15547 (2002).
15. Perrimon, N. Signalling pathways initiated by receptor protein tyrosine kinases in Drosophila. Curr. Opin. Cell Biol. 6, 260-266 (1994).
16. Kornfeld, K. Vulval development in Caenorhabditis elegans. Trends Genet. 13, 55-61 (1997).
17. Nolan, P. M. et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature Genet. 25, 440-443 (2000). An excellent overview of one of the first two large-scale programmes that use ethylnitrosourea (ENU).
18. Loy, A. L. & Goodnow, C. C. Novel approaches for identifying genes regulating lymphocyte development and function. Curr. Opin. Immunol. 14, 260-265 (2002).
19. Hrabe de Angelis, M. H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nature Genet. 25, 444-447 (2000). An overview of the pioneering ENU-mutagenesis programme carried out as part of the German Human Genome Project. It accompanies reference 17, which describes a corresponding effort carried out in the United Kingdom.
20. Noveroske, J. K., Weber, J. S. & Justice, M. J. The mutagenic action of N-ethyl-N-nitrosourea in the mouse. Mamm. Genome 11, 478-483 (2000).
21. Justice, M. J. et al. Effects of ENU dosage on mouse strains. Mamm. Genome 11, 484-488 (2000).
22. Russell, W. L. et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl Acad. Sci. USA 16, 5818-5819 (1979).
23. Flaswinkel, H. et al. Identification of immunological relevant phenotypes in ENU mutagenized mice. Mamm. Genome 11, 526-527 (2000). The first description of a large-scale ENU screen for mutations that affect the development of the immune system. This entire volume of Mammalian Genome is devoted to ENU mutagenesis.
24. Nelms, K. A. & Goodnow, C. C. Genome-wide ENU mutagenesis to reveal immune regulators. Immunity 15, 409-418 (2001).
25. Beier, D. R. ENU mutagenesis: a work in progress. Physiol. Genomics 11, 111-113 (2002).
26. Miosge, L. A., Blasioti, J., Blery, M. & Goodnow, C. C. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor κB2 in regulating circulating B cell numbers. J. Exp. Med. 196, 1113-1119 (2002).
27. + T cell development in the thymus. Cell 108, 755-767 (2002).
28. Ryding, A. D., Sharp, M. G. & Mullins, J. J. Conditional transgenic technologies. J. Endocrinol. 171, 1-14 (2001).